Ozempic, Wegovy ingredient may lower risk of Alzheimer’s, study finds
Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...
Novo Nordisk posts Q3 sales of obesity drug Wegovy above forecast
Novo Nordisk on Wednesday reported better-than-expected quarterly sales of its popular Wegovy weight-loss drug and narrowed ...
Novo Nordisk’s Wegovy Sales Surge on Crucial US Market
Novo Nordisk A/S’s sales of the blockbuster weight-loss drug Wegovy leapt in the third quarter, a potential relief for ...
Novo Nordisk’s Blockbuster Wegovy Sales Beat Expectations
The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.
NBC Los Angeles3h
Novo Nordisk quarterly profit meets expectations as Wegovy maker narrows full-year guidance
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...
Medical News Today15h
Can Ozempic and Wegovy help reduce knee osteoarthritis-related pain?
Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...
Novo Nordisk’s Wegovy sales jump on international rollouts
Novo’s obesity drug sales nearly doubled outside the U.S. during the quarter as global demand continued to rise.
pharmaphorum1h
Wegovy romps ahead after key rival sees slowdown
GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...
STAT1h
Novo’s earnings report sends shares up, as obesity drug sales show continued growth
Novo Nordisk shares were up Wednesday following an earnings report that showed continued sales growth of its obesity drug.
Novo Nordisk's Blockbuster Wegovy Sales Beat Expectations — Update
Novo Nordisk's net profit in the third quarter rose 21% to 27.3 billion kroner, ahead of the 26.79 billion kroner forecast by analysts in a FactSet poll. Sales rose 21% to 71.31 billion kroner, ...